Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Schering-Plough prepares arylalkylamines as neurokinin antagonists

Sep. 10, 1998

Novel WHI compound inhibits 5-LO translocation in mast cells

Sep. 9, 1998

Bradykinin B2 antagonists in the pipeline at Fournier

Sep. 7, 1998

NK2 antagonist saredutant prevents NKA-induced bronchoconstriction in asthmatic subjects

Sep. 4, 1998

New neurokinin antagonists from Schering-Plough especially useful for asthma

Sep. 3, 1998

Cheil Jedang discloses PDE IV inhibitors for treating asthma

Sep. 1, 1998

More alpha2-adrenoceptor agonists in the pipeline at Procter & Gamble

Sep. 1, 1998

Unique asthma medication launched in Canada

Sep. 1, 1998

Research on alpha2-agonists continues at P&G

Aug. 31, 1998

P&G reports alpha2-adrenoceptor agonists for treating nasal congestion

Aug. 28, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 30, 2026.
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026